Torisel, Sutent, Nexavar Combinations Are “Future” Of RCC Treatment – Wyeth Exec

Wyeth plans to look at drug combinations in the kidney cancer arena using its renal cell carcinoma candidate Torisel.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet